[CHRS] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
06-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 16.79%
YoY- 72.88%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 70,774 74,568 45,424 82,503 113,551 111,684 0 -
PBT -10,751 -40,021 -86,650 -38,528 28,116 47,890 -58,826 -24.64%
Tax 0 -380 6,201 5,801 183 847 2,978 -
NP -10,751 -39,641 -92,851 -38,528 27,933 47,043 -58,808 -24.64%
Tax Rate - - - - -0.65% -1.77% - -
Total Cost 81,525 114,209 138,275 121,031 85,618 64,641 58,808 5.58%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -15.19 -53.16 -204.41 -46.70 24.60 42.12 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.09 -0.41 -1.19 -0.49 0.39 0.67 -0.87 -31.46%
EPS Diluted -0.09 -0.41 -1.19 -0.49 0.33 0.63 -0.87 -31.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.